[1]
|
Angela, L., et al. (2020) Cholangiocarcinoma 2020: The Next Horizon in Mechanisms and Management. Nature Reviews Gastroenterology Hepatology, 17, 557-588.
|
[2]
|
Rizvi, S. and Gores, J.G. (2013) Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma. Gastroenterology, 145, 1215-1229. https://doi.org/10.1053/j.gastro.2013.10.013
|
[3]
|
Katie, R.K., Bruno, N., et al. (2021) Biliary Tract Cancer. The Lancet, 397, 428-444. https://doi.org/10.1016/S0140-6736(21)00153-7
|
[4]
|
Primrose, N.J., Fox, P.R., Palmer, H.D., et al. (2018) Capecitabine Compared with Observation in Resected Biliary Tract Cancer (BILCAP): A Randomised, Controlled, Multicentre, Phase 3 Study. The Lancet Oncology, 20, 663-673.
|
[5]
|
Anastasiadou, E., Jacob, L.S. and Slack, F.J. (2018) Non-Coding RNA Networks in Cancer. Nature Reviews Cancer, 18, 5-18.
|
[6]
|
Slack, J.F. and Chinnaiyan, M.A. (2019) The Role of Non-Coding RNAs in Oncology. Cell, 179, 1033-1055. https://doi.org/10.1016/j.cell.2019.10.017
|
[7]
|
Luo, M., et al. (2023) Circular RNA circPOFUT1 Enhances Malignant Phenotypes and Autophagy-Associated Chemoresistance via Sequestrating MiR-488-3p to Activate the PLAG1-ATG12 Axis in Gastric Cancer. Cell Death Disease, 14, Article No. 10. https://doi.org/10.1038/s41419-022-05506-0
|
[8]
|
Xu, Y.J. (2022) MiRNA-21-5p Accelerates EMT and Inhibits Apoptosis of Laryngeal Carcinoma via Inhibiting KLF6 Expression. Biochemical Genetics, 61, 101-115. https://doi.org/10.1007/s10528-022-10246-z
|
[9]
|
Liang, Z.Q., Zhu, B.S., Meng, D.D., et al. (2019) Down-Regulation of lncRNA-NEF Indicates Poor Prognosis in Intrahepatic Cholangiocarcinoma. Bioscience Reports, 39, BSR20181573. https://doi.org/10.1042/BSR20181573
|
[10]
|
Du, H.M., Hou, S.L., Zhang, L.C., et al. (2023) lncRNA FALEC Increases the Proliferation, Migration and Drug Resistance of Cholangiocarcinoma through Competitive Regulation of MiR-20a-5p/SHOC2 Axis. Aging, 15, 3759-3770. https://doi.org/10.18632/aging.204709
|
[11]
|
Cui, C., Yang, J., Li, X., Liu, D., Fu, L. and Wang, X. (2020) Functions and Mechanisms of Circular RNAs in Cancer Radiotherapy and Chemotherapy Resistance. Molecular Cancer, 19, Article No. 58. https://doi.org/10.1186/s12943-020-01180-y
|
[12]
|
Bartel, D.P. (2004) microRNAs: Genomics, Biogenesis, Mechanism, and Function. Cell, 116, 281-297. https://doi.org/10.1016/S0092-8674(04)00045-5
|
[13]
|
He, B., Zhao, Z., Cai, Q., et al. (2020) MiRNA-Based Biomarkers, Therapies, and Resistance in Cancer. International Journal of Biological Sciences, 16, 2628-2647. https://doi.org/10.7150/ijbs.47203
|
[14]
|
Zou, Y., Li, R., Kuang, D., et al. (2020) Galangin Inhibits Cholangiocarcinoma Cell Growth and Metastasis through Downregulation of microRNA-21 Expression. BioMed Research International, 2020, Article ID: 5846938. https://doi.org/10.1155/2020/5846938
|
[15]
|
Meng, F., Henson, R., Lang, M., et al. (2006) Involvement of Human micro-RNA in Growth and Response to Chemotherapy in Human Cholangiocarcinoma Cell Lines. Gastroenterology, 130, 2113-2129. https://doi.org/10.1053/j.gastro.2006.02.057
|
[16]
|
Liu, R., Chen, Y., Liu, G., Li, C., Song, Y., Cao, Z., et al. (2020) PI3K/AKT Pathway as a Key Link Modulates the Multidrug Resistance of Cancers. Cell Death & Disease, 11, Article No. 797. https://doi.org/10.1038/s41419-020-02998-6
|
[17]
|
Du, H., Hou, S., Zhang, L., Liu, C., Yu, T. and Zhang, W. (2023) lncRNA FALEC Increases the Proliferation, Migration and Drug Resistance of Cholangiocarcinoma through Competitive Regulation of MiR-20a-5p/SHOC2 Axis. Aging (Albany NY), 15, 3759-3770. https://doi.org/10.18632/aging.204709
|
[18]
|
Roskoski, R. (2019) Targeting ERK1/2 Protein-Serine/Threonine Kinases in Human Cancers. Pharmacological Research, 142, 151-168. https://doi.org/10.1016/j.phrs.2019.03.019
|
[19]
|
Li, Q., Xia, X., Ji, J., et al. (2017) MiR-199a-3p Enhances Cisplatin Sensitivity of Cholangiocarcinoma Cells by Inhibiting MTOR Signaling Pathway and Expression of MDR1. Oncotarget, 8, 33621-33630. https://doi.org/10.18632/oncotarget.16834
|
[20]
|
Li, J., Jiang, X., Li, Z., et al. (2020) SP1-Induced HOXD-AS1 Promotes Malignant Progression of Cholangiocarcinoma by Regulating MiR-520c-3p/MYCN. Aging (Albany NY), 12, 16304-16325. https://doi.org/10.18632/aging.103660
|
[21]
|
Lu, M., Qin, X., Zhou, Y., et al. (2021) Long Non-Coding RNA LINC00665 Promotes Gemcitabine Resistance of Cholangiocarcinoma Cells via Regulating EMT and Stemness Properties through MiR-424-5p/BCL9L Axis. Cell Death & Disease, 12, Article No. 72. https://doi.org/10.1038/s41419-020-03346-4
|
[22]
|
Li, J., Jiang, X., Xu, Y., et al. (2022) YY1-Induced DLEU1/MiR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2. International Journal of Biological Sciences, 18, 4301-4315. https://doi.org/10.7150/ijbs.66224
|
[23]
|
Shen, S., Wang, J., Zheng, B., et al. (2020) LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma. Molecular Therapy—Nucleic Acids, 19, 446-457. https://doi.org/10.1016/j.omtn.2019.11.028
|
[24]
|
Yao, S., Fan, Y.L. and Lam, W.E. (2018) The FOXO3-FOXM1 Axis: A Key Cancer Drug Target and a Modulator of Cancer Drug Resistance. Seminars in Cancer Biology, 50, 77-89. https://doi.org/10.1016/j.semcancer.2017.11.018
|
[25]
|
Zhang, L., Ma, D., Li, F., Qiu, G., Sun, D. and Zeng, Z. (2022) lnc-PKD2-2-3/MiR-328/GPAM ceRNA Network Induces Cholangiocarcinoma Proliferation, Invasion and 5-FU Chemoresistance. Frontiers in Oncology, 12, Article ID: 871281. https://doi.org/10.3389/fonc.2022.871281
|
[26]
|
Du, J., Lan, T., Liao, H., et al. (2023) Correction: CircNFIB Inhibits Tumor Growth and Metastasis through Suppressing MEK1/ERK Signaling in Intrahepatic Cholangiocarcinoma. Molecular Cancer, 22, Article No. 134. https://doi.org/10.1186/s12943-023-01836-5
|
[27]
|
Lu, Q. and Fang, T. (2020) Circular RNA SMARCA5 Correlates with Favorable Clinical Tumor Features and Prognosis, and Increases Chemotherapy Sensitivity in Intrahepatic Cholangiocarcinoma. Journal of Clinical Laboratory Analysis, 34, E23138. https://doi.org/10.1002/jcla.23138
|
[28]
|
Wang, G., Gao, X., Sun, Z., et al. (2023) Circular RNA SMARCA5 Inhibits Cholangiocarcinoma via microRNA-95-3p/Tumor Necrosis Factor Receptor Associated Factor 3 Axis. Anticancer Drugs, 34, 1002-1009. https://doi.org/10.1097/CAD.0000000000001487
|